Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-1b)
Condition: Decompensated Cirrhosis Intervention: Biological: Human Umbilical Cord-derived Mesenchymal Stem Cells Sponsors: Beijing 302 Hospital; Wuhan Optics Valley Zhongyuan Pharmaceutical Co., Ltd., Hubei, China Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: China Health | Cirrhosis | COVID-19 | Hospitals | Research | Stem Cell Therapy | Stem Cells